According to the latest report by IMARC Group, titled "Artificial Disc Market Report by Disc Type (Cervical Artificial Disc, Lumbar Artificial Disc), Material Type (Metal on Polymer, Metal on Metal), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and Region 2025-2033," the global artificial disc market reached a value of USD 3.6 Billion in 2024. An artificial disc is a medical device that is used to replace a damaged or degenerated spinal disc in the spine. The spinal discs are soft, gel-like cushions that sit between the vertebrae and help to absorb shock and provide flexibility to the spine. It is designed to mimic the natural function of a healthy spinal disc. It is typically made of metal, plastic, or a combination of both and comes in a variety of shapes and sizes to fit different spinal levels and patient needs. It is inserted into the space left by the removed disc during a surgical procedure called artificial disc replacement (ADR). It comprises two endplates made of titanium alloy, cobalt-chromium, or medical-grade polyethylene. It is compressible, allowing for flexibility and movement while reducing back strain. It uses motion-sparing technology to maintain extended motion and lateral bending. Healthcare professionals recommend artificial discs as they provide a decent level of mobility restoration as compared to spinal fusion surgery.
Global Artificial Disc Market Trends:
The global market is primarily driven by the increasing prevalence of spinal disorders. In line with this, the growing demand for minimally invasive surgical procedures is significantly contributing to the market growth. Furthermore, the ongoing technological advancements and the expansion of healthcare infrastructure in developing economies are positively influencing the market. Apart from this, the rising number of artificial spine disc replacement surgeries is catalyzing the market. Moreover, the escalating prevalence of degenerative disc diseases and the insertion of superior artificial spine discs leading to greater ease and mobility for the patient are propelling the market. Besides, the rising mergers and acquisitions by the companies involved in the artificial spine disc market are expected to favor the market. Additionally, the growing number of trauma-related and sports injuries and orthopedic surgeries is providing a boost to the market. On account of the factors above, the market is anticipated to reach a value of USD 13.8 Billion by 2033, exhibiting a CAGR of 15.24% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Disc Type, Material Type, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Depuy Synthes Inc. (Johnson & Johnson), Globus Medical Inc., Medtronic plc, Nuvasive Inc., Orthofix Medical Inc., Paradigm Spine LLC (RTI Surgical Holdings Inc.), Smith & Nephew Plc, Stryker Corporation and Zimmer Biomet Holdings Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800